Role of stress peptides during human pregnancy and labour

Premature birth is the major source of perinatal death and disability. Furthermore, the intrauterine health of the baby is important for preventing certain adult diseases. However, the molecular mechanisms driving the onset of human labour remain uncertain, although several key players have been identified. It is becoming clear that there are many pathways to parturition in humans. Stress peptides, in particular placental corticotrophin releasing hormone (CRH) and possibly the related peptide urocortin, appear to play important roles throughout pregnancy. Plasma CRH is a predictor of the duration of human gestation. During most of pregnancy, CRH, acting via specific CRH receptor subtypes, plays a 'protective' role by promoting myometrial quiescence via the generation of cAMP and cGMP, and upregulation of nitric oxide synthase expression. At term, myometrial contractility is enhanced by a complex series of molecular switches, involving the upregulation of oxytocin receptor expression and crosstalk between the oxytocin and CRH receptors. This results in protein kinase C-induced phosphorylation of specific CRH receptor subtypes, with subsequent desensitization and a shift in the intracellular microenvironment to enhance contractility. CRH/urocortin, via specific receptor isoforms, is now able to activate Gq and potentially enhance the oxytocin-driven generation of inositol triphosphate. In addition, CRH/urocortin, via specific CRH receptor subtypes, may generate prostaglandins from the fetal membranes and decidua, play a role in placental vasodilatation and participate in fetal adrenal function and organ maturation. These peptides and receptors are phylogenetically ancient and well preserved across species. They may have evolved as a mechanism to protect against the 'stress' of premature birth.

This article has been cited by other articles:

				P. Florio, R. Romero, T. Chaiworapongsa, J. P. Kusanovic, M. Torricelli, P. J. Lowry, and F. Petraglia Amniotic Fluid and Umbilical Cord Plasma Corticotropin-Releasing Factor (CRF), CRF-Binding Protein, Adrenocorticotropin, and Cortisol Concentrations in Intraamniotic Infection and Inflammation at Term J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3604 - 3609. [Abstract] [Full Text] [PDF]

				V. Minas, U. Jeschke, S.N. Kalantaridou, D.U. Richter, T. Reimer, I. Mylonas, K. Friese, and A. Makrigiannakis Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin Mol. Hum. Reprod., September 1, 2007; 13(9): 663 - 673. [Abstract] [Full Text] [PDF]

				G. Mastorakos, E. I Karoutsou, and M. Mizamtsidi Corticotropin releasing hormone and the immune/inflammatory response Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S77 - S84. [Abstract] [Full Text] [PDF]

				E. Marinoni, C. Zacharopoulou, A. Di Rocco, C. Letizia, M. Moscarini, and R. Di Iorio Effect of Betamethasone In Vivo on Placental Adrenomedullin in Human Pregnancy Reproductive Sciences, September 1, 2006; 13(6): 418 - 424. [Abstract] [PDF]

				E. W. Hillhouse and D. K. Grammatopoulos The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology Endocr. Rev., May 1, 2006; 27(3): 260 - 286. [Abstract] [Full Text] [PDF]

				R. J. Denver and E. J. Crespi Stress Hormones and Human Developmental Plasticity: Lessons From Tadpoles NeoReviews, April 1, 2006; 7(4): e183 - e188. [Full Text] [PDF]

				M. Torricelli, E. Ignacchiti, A. Giovannelli, A. Merola, E. Scarpetti, G. Calonaci, E. Picciolini, P. Florio, F. M Reis, E. A Linton, et al. Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies Eur. J. Endocrinol., February 1, 2006; 154(2): 281 - 285. [Abstract] [Full Text] [PDF]

				S. Schlatt, A. Honaramooz, J. Ehmcke, P.J. Goebell, H. Rubben, R. Dhir, I. Dobrinski, and P. Patrizio Limited survival of adult human testicular tissue as ectopic xenograft Hum. Reprod., February 1, 2006; 21(2): 384 - 389. [Abstract] [Full Text] [PDF]

				J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment Endocr. Rev., October 1, 2005; 26(6): 775 - 799. [Abstract] [Full Text] [PDF]

				K. E. Orwig and S. Schlatt Cryopreservation and Transplantation of Spermatogonia and Testicular Tissue for Preservation of Male Fertility J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 51 - 56. [Abstract] [Full Text] [PDF]

				T. C. Theoharides, B. Madhappan, D. Kempuraj, and N. Papadopoulou Authors' Response: High Levels of Intrauterine Corticotrophin-Releasing Hormone, Urocortin, Tryptase, and Interleukin-8 in Spontaneous Abortions J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5580 - 5581. [Full Text] [PDF]

				N. Alfaidy, W. Li, T. MacIntosh, K. Yang, and J. Challis Late Gestation Increase in 11{beta}-Hydroxysteroid Dehydrogenase 1 Expression in Human Fetal Membranes: A Novel Intrauterine Source of Cortisol J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5033 - 5038. [Abstract] [Full Text] [PDF]